Found 6 matching trials
Long-Acting Treatment in Adolescents (LATA)
PHASE3The LATA trial will find out if taking a long-acting injectable form of HIV...
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
PHASE1This is a Phase I/II, multicenter, open-label, non-randomized study with fo...
Location
Site 4601, University of California, UC San Diego CRS- Mother-Child-Adolescent HIV Program
Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)
PHASE3Chronic human immunodeficiency virus (HIV) infection in adults continues to...
Location
GSK Investigational Site
Long Acting Cabotegravir Plus Rilpivirine in People Living with HIV-1 Aged ≥ 60 Years for 24 Months.
PHASE4People Living with HIV-1 (PLHIV) are an important group of patients attendi...
Location
Hospital General Universitario de Elche
A Sub-study of Cabotegravir (CAB) and Rilpivirine (RPV) in Human Immunodeficiency Viruses (HIV)-Infected Participants
PHASE3This sub-study will assess the pharmacokinetics (PK), safety, tolerability,...
Location
GSK Investigational Site
Improving HIV-1 Control in Africa with Long Acting Antiretrovirals
PHASE3IMPALA is a randomized, open-label, multicenter, interventional study of 54...
Status
Active Not Recruiting
Location
Jaramogi Oginga Odinga Teaching & Referral Hospital